PALOMA-3: palbociclib and fulvestrant for HR-/HER+ metastatic breast cancer
Trial updates in breast cancer from ASCO: TAILORx, PAKT, MONARCH 2 & MONALEESA-3
What have we learned from recent clinical trials in early breast cancer treatment?
The significance of fulvestrant for hormone receptor-positive advanced breast cancer
Design and results of Phase III FALCON trial of fulvestrant for advanced breast cancer
FALCON trial of fulvestrant for advanced breast cancer: subgroup analysis and overall survival